Danaher Corporation $DHR Position Raised by Ritholtz Wealth Management

Ritholtz Wealth Management grew its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 29.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 12,634 shares of the conglomerate’s stock after acquiring an additional 2,860 shares during the quarter. Ritholtz Wealth Management’s holdings in Danaher were worth $2,799,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors also recently modified their holdings of DHR. Marquette Asset Management LLC increased its holdings in shares of Danaher by 192.1% in the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock worth $25,000 after acquiring an additional 73 shares during the period. N.E.W. Advisory Services LLC bought a new stake in Danaher in the 2nd quarter valued at about $25,000. Main Street Group LTD bought a new stake in Danaher in the 1st quarter valued at about $25,000. Field & Main Bank bought a new stake in Danaher in the 2nd quarter valued at about $29,000. Finally, Joseph Group Capital Management boosted its stake in Danaher by 62.4% during the 3rd quarter. Joseph Group Capital Management now owns 151 shares of the conglomerate’s stock valued at $33,000 after purchasing an additional 58 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Price Performance

Shares of DHR opened at $233.16 on Monday. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The stock’s fifty day moving average is $222.56 and its 200-day moving average is $201.52. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.29 and a current ratio of 1.63. The firm has a market capitalization of $164.04 billion, a price-to-earnings ratio of 38.16, a price-to-earnings-growth ratio of 2.93 and a beta of 0.76.

Danaher (NYSE:DHR – Get Free Report) last posted its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share for the quarter, topping the consensus estimate of $1.92 by $0.19. The business had revenue of $6.55 billion during the quarter, compared to the consensus estimate of $6.56 billion. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The company’s quarterly revenue was up 8.3% compared to the same quarter last year. During the same quarter in the prior year, the company posted $1.89 earnings per share. Equities analysts anticipate that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date was Wednesday, September 30th. Danaher’s payout ratio is 26.19%.

Wall Street Analysts Forecast Growth

Several research analysts have commented on DHR shares. Morgan Stanley upped their target price on shares of Danaher from $220.00 to $240.00 and gave the stock an “overweight” rating in a research report on Monday, October 12th. Royal Bank Of Canada lifted their price target on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. Stifel Nicolaus lifted their price target on Danaher from $220.00 to $260.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Wells Fargo & Company reduced their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Finally, Deutsche Bank reissued a “buy” rating and issued a $240.00 price objective on shares of Danaher in a report on Wednesday, July 22nd. Eighteen equities research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $242.91.

Get Our Latest Analysis on DHR

Insider Transactions at Danaher

In other news, EVP Gregory Milosevich sold 2,100 shares of the company’s stock in a transaction that occurred on Monday, November 9th. The shares were sold at an average price of $230.62, for a total value of $484,302.00. Following the completion of the sale, the executive vice president directly owned 22,367 shares of the company’s stock, valued at approximately $5,158,277.54. This represents a 8.58% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Christopher Bouda sold 7,598 shares of the company’s stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total transaction of $1,782,186.88. Following the completion of the sale, the chief accounting officer directly owned 9,107 shares of the company’s stock, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 10.80% of the stock is currently owned by insiders.

Danaher Company Profile

(Free Report)

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.

Featured Stories

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.